{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_6040", "batch_size": 200, "batch_pos": 152, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, superlative + negative noun, or critical alert phrase.", "method": "llm_batch", "batch_id": "batch_2_13368", "batch_size": 200, "batch_pos": 139, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment contains a statement about uncertainty, not a moderate verb paired with explicit scale or impact.", "method": "llm_batch", "batch_id": "batch_3_9176", "batch_size": 200, "batch_pos": 110, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_3884", "batch_size": 200, "batch_pos": 97, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports uncertainty without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_7588", "batch_size": 200, "batch_pos": 95, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_9176", "batch_size": 200, "batch_pos": 84, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment describes uncertainty ('too early to tell') not a bare negation about the virus.", "method": "llm_batch", "batch_id": "batch_7_19056", "batch_size": 200, "batch_pos": 78, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "'too early to tell how many doses Moderna will be able to manufacture' describes a capability/potential.", "method": "llm_batch", "batch_id": "batch_8_17160", "batch_size": 200, "batch_pos": 49, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
